7V91 Stock Overview
Provides healthcare technology and services in France and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Visiomed Group SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.18 |
52 Week High | €0.56 |
52 Week Low | €0.17 |
Beta | -0.50 |
1 Month Change | 1.10% |
3 Month Change | -23.67% |
1 Year Change | -55.67% |
3 Year Change | n/a |
5 Year Change | -80.02% |
Change since IPO | -98.76% |
Recent News & Updates
Recent updates
Shareholder Returns
7V91 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -4.3% | 3.6% | 0.6% |
1Y | -55.7% | -0.03% | 5.4% |
Return vs Industry: 7V91 underperformed the German Medical Equipment industry which returned -0% over the past year.
Return vs Market: 7V91 underperformed the German Market which returned 5.4% over the past year.
Price Volatility
7V91 volatility | |
---|---|
7V91 Average Weekly Movement | 8.9% |
Medical Equipment Industry Average Movement | 4.5% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.4% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 7V91's share price has been volatile over the past 3 months.
Volatility Over Time: 7V91's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 73 | Clement Pacaud | www.visiomed.fr |
Visiomed Group SA, together with its subsidiaries, provides healthcare technology and services in France and internationally. It offers BewellConnect, an eco-system of health solutions including enriched and assisted teleconsultation, remote home monitoring, hospital monitoring, tele-expertise, tele-assistance, and tele-regulations; and Smart Salem, a medical fitness screening device. Visiomed Group SA was founded in 2007 and is headquartered in Paris, France.
Visiomed Group SA Fundamentals Summary
7V91 fundamental statistics | |
---|---|
Market cap | €57.03m |
Earnings (TTM) | -€3.54m |
Revenue (TTM) | €12.04m |
4.7x
P/S Ratio-16.1x
P/E RatioIs 7V91 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
7V91 income statement (TTM) | |
---|---|
Revenue | €12.04m |
Cost of Revenue | €7.28m |
Gross Profit | €4.76m |
Other Expenses | €8.30m |
Earnings | -€3.54m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.012 |
Gross Margin | 39.53% |
Net Profit Margin | -29.39% |
Debt/Equity Ratio | 35.7% |
How did 7V91 perform over the long term?
See historical performance and comparison